Abstract
Background: Multiple strategies have been recommended for prevention and control of antibacterial resistance. Solutions will need to be found soon if we are not to run the serious risk of losing the ability to treat bacterial infections, especially the ones arising from multi-resistant strains. Deep knowledge of the resistance mechanisms followed by novel therapeutic drugs and vaccines are needed. A consolidated, multidisciplinary and regulated strategy is required by this challenge.
Objective: This review will be focused on new strategies to control infections. Among strategies to tackle antibiotic resistance that have been under investigation, are the use of antimicrobial peptides, phage therapy and phage enzymes, therapeutic antibodies, quorum sensing inhibitors and, finally, the antibacterial nanomedicines. Although all of the approaches seem to be effective, and at least one of them has been in use for relatively a long time (phage therapy), antibacterial nanomedicines show the most diverse range of different approaches regarding potential translation to clinics. Results & Conclusion: Several advances have been made but a great effort is still mandatory in order to reach feasible, effective and marketable novel antimicrobial products.Keywords: Antibacterial nanomedicines, antibiotic resistance, antimicrobial peptides, bacteriophages, monoclonal antibodies, quorum-sensing inhibitors.
Mini-Reviews in Medicinal Chemistry
Title:Novel Antibacterial Agents: An Emergent Need to Win the Battle Against Infections
Volume: 17 Issue: 14
Author(s): Natércia G. Simões, Ana F. Bettencourt, Nuno Monge and Isabel A.C. Ribeiro*
Affiliation:
- Faculdade de Farmácia, Universidade Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa,Portugal
Keywords: Antibacterial nanomedicines, antibiotic resistance, antimicrobial peptides, bacteriophages, monoclonal antibodies, quorum-sensing inhibitors.
Abstract: Background: Multiple strategies have been recommended for prevention and control of antibacterial resistance. Solutions will need to be found soon if we are not to run the serious risk of losing the ability to treat bacterial infections, especially the ones arising from multi-resistant strains. Deep knowledge of the resistance mechanisms followed by novel therapeutic drugs and vaccines are needed. A consolidated, multidisciplinary and regulated strategy is required by this challenge.
Objective: This review will be focused on new strategies to control infections. Among strategies to tackle antibiotic resistance that have been under investigation, are the use of antimicrobial peptides, phage therapy and phage enzymes, therapeutic antibodies, quorum sensing inhibitors and, finally, the antibacterial nanomedicines. Although all of the approaches seem to be effective, and at least one of them has been in use for relatively a long time (phage therapy), antibacterial nanomedicines show the most diverse range of different approaches regarding potential translation to clinics. Results & Conclusion: Several advances have been made but a great effort is still mandatory in order to reach feasible, effective and marketable novel antimicrobial products.Export Options
About this article
Cite this article as:
Simões G. Natércia, Bettencourt F. Ana , Monge Nuno and Ribeiro A.C. Isabel*, Novel Antibacterial Agents: An Emergent Need to Win the Battle Against Infections, Mini-Reviews in Medicinal Chemistry 2017; 17 (14) . https://dx.doi.org/10.2174/1389557516666160907151454
DOI https://dx.doi.org/10.2174/1389557516666160907151454 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
Natural Products in Drug Discovery
Natural products have always been one of the important ways of drug discovery due to their novel skeleton and diverse functional group characteristics. According to statistics, between 1981 and 2019, the FDA approved a total of 1,394 small molecule drugs for marketing, of which 930 marketed drugs originated from the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
KEMREP: A New Qualitative Method for the Assessment of an Analyst’s Ability to Generate a Metabolomics Data Matrix by Gas Chromatography– Mass Spectrometry
Current Metabolomics COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods
Anti-Cancer Agents in Medicinal Chemistry West Nile Viral Meningoencephalitis in an Immunocompetent Female: A Case Report from Western Rajasthan, India
Infectious Disorders - Drug Targets The Possibilities and Pitfalls for Anti-Complement Therapies in Inflammatory Diseases
Current Drug Targets - Inflammation & Allergy Evaluating a Child with Partial Developmental Delay (ParDD), Global Developmental Delay (GDD)/Mental Retardation (MR): Clinical Expertise Based or Evidence-Based?
Current Pediatric Reviews Development and Validation of Microbiological Assay for Ceftriaxone and its Application in Photo-stability Study
Current Pharmaceutical Analysis Neutrophil Activation Induced by Plant Lectins: Modulation of Inflammatory Processes
Inflammation & Allergy - Drug Targets (Discontinued) Nanoformulated Antibiotics: the Next Step for Pathogenic Bacteria Control
Current Medicinal Chemistry Challenges and Opportunities for Bacterial Vaccine Development in the 21<sup>st</sup> Century
Current Pharmaceutical Biotechnology Is there a Role for Bevacizumab in Non-Glial Tumors?
Current Drug Targets Endotoxin Neutralizing Peptides
Current Topics in Medicinal Chemistry Listeria-Based Anti-Infective Vaccine Strategies
Recent Patents on Anti-Infective Drug Discovery A Review on Nuclear Imaging as a Promising Modality for Efficient Diagnosis of Tuberculosis
Current Medical Imaging Brain Perfusion In Sepsis
Current Vascular Pharmacology Beyond Oncolytic Virotherapy: Replication-Competent Retrovirus Vectors for Selective and Stable Transduction of Tumors
Current Gene Therapy The Blood-Brain Barrier: Targeting in the Pathogenesis of C. neoformans Meningitis and Drug Discovery
Anti-Infective Agents Cerebral Collateral Circulation in Carotid Artery Disease
Current Cardiology Reviews Prospective Evaluation of the Dosing Regimen of Vancomycin in Children of Different Weight Categories
Current Drug Safety TB Diagnostics – Old and New
Current Respiratory Medicine Reviews The Urokinase Receptor in the Central Nervous System
CNS & Neurological Disorders - Drug Targets